Short-term survival and safety of apatinib combined with oxaliplatin and S-1 in the conversion therapy of unresectable gastric cancer

BACKGROUND: We conducted a single-arm phase II trial to investigate the short-term efficacy and safety of apatinib combined with oxaliplatin and S-1 in the treatment of unresectable gastric cancer. PATIENTS AND METHODS: Previously untreated patients with unresectable HER-2-negative advanced gastric...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Zaisheng, Zeng, Yi, Wei, Shenghong, Wang, Yi, Lin, Zhitao, Chen, Shu, Wang, Zhiwei, Chen, Shanshan, Chen, Luchuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204414/
https://www.ncbi.nlm.nih.gov/pubmed/34126957
http://dx.doi.org/10.1186/s12885-021-08459-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204414/
https://www.ncbi.nlm.nih.gov/pubmed/34126957
http://dx.doi.org/10.1186/s12885-021-08459-3

Ejemplares similares